Current guidelines for the treatment of diabetes are specific to type 1 and type 2 diabetes (T1D and T2D) and these show marked differences,1–4 reflecting the difference in endogenous insulin production between the two subtypes. This evidence concerns the gene INS and type 1 diabetes mellitus.